Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zia Poonja

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Bronchology & Interventional Pulmonology|July 17, 2013
Endobronchial hamartomaZia Poonja, Allan Sobey, Justin G Weinkauf
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 18, 2015
Localized prostate cancer presenting as a renal pseudo-tumourZia Poonja, Alan So, Bernhard J Eigl
Current Opinion in Supportive and Palliative Care|November 26, 2013
Social media in cancer care: opportunities to improve care in locally advanced breast cancerChristine Simmons, Yanchini Rajmohan, Zia Poonja, et al.
Clinical Lung Cancer|October 20, 2018
Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter AnalysisDoran Ksienski, Elaine S Wai, Nicole Croteau, et al.
Journal of Geriatric Oncology|January 16, 2020
Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumabDoran Ksienski, Elaine S Wai, Nicole S Croteau, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practiceDoran Ksienski, Elaine S Wai, Nicole Croteau, et al.
Translational Lung Cancer Research|February 11, 2021
Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumabDoran Ksienski, Elaine S Wai, Deepu Alex, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2025
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLCBarbara Melosky, Quincy S C Chu, Rosalyn A Juergens, et al.
Cancers|July 29, 2023
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and NeckAnagha Gogate, Bryan Bennett, Zia Poonja, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Bronchology & Interventional Pulmonology|July 17, 2013
Endobronchial hamartomaZia Poonja, Allan Sobey, Justin G Weinkauf
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 18, 2015
Localized prostate cancer presenting as a renal pseudo-tumourZia Poonja, Alan So, Bernhard J Eigl
Current Opinion in Supportive and Palliative Care|November 26, 2013
Social media in cancer care: opportunities to improve care in locally advanced breast cancerChristine Simmons, Yanchini Rajmohan, Zia Poonja, et al.
Clinical Lung Cancer|October 20, 2018
Efficacy of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer Needing Treatment Interruption Because of Adverse Events: A Retrospective Multicenter AnalysisDoran Ksienski, Elaine S Wai, Nicole Croteau, et al.
Journal of Geriatric Oncology|January 16, 2020
Association of age with differences in immune related adverse events and survival of patients with advanced nonsmall cell lung cancer receiving pembrolizumab or nivolumabDoran Ksienski, Elaine S Wai, Nicole S Croteau, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Pembrolizumab for advanced nonsmall cell lung cancer: Efficacy and safety in everyday clinical practiceDoran Ksienski, Elaine S Wai, Nicole Croteau, et al.
Translational Lung Cancer Research|February 11, 2021
Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumabDoran Ksienski, Elaine S Wai, Deepu Alex, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2025
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLCBarbara Melosky, Quincy S C Chu, Rosalyn A Juergens, et al.
Cancers|July 29, 2023
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and NeckAnagha Gogate, Bryan Bennett, Zia Poonja, et al.
Pageof 1